[HTML][HTML] Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders

RF Spaide, CMG Cheung, H Matsumoto, S Kishi… - Progress in retinal and …, 2022 - Elsevier
In central serous chorioretinopathy (CSC), the macula is detached because of fluid leakage
at the level of the retinal pigment epithelium. The fluid appears to originate from choroidal …

[HTML][HTML] Central serous chorioretinopathy: towards an evidence-based treatment guideline

TJ Van Rijssen, EH Van Dijk, S Yzer… - Progress in retinal and …, 2019 - Elsevier
Central serous chorioretinopathy (CSC) is a common cause of central vision loss, primarily
affecting men 20–60 years of age. To date, no consensus has been reached regarding the …

Central serous chorioretinopathy: pathogenesis and management

F Semeraro, F Morescalchi, A Russo… - Clinical …, 2019 - Taylor & Francis
Central serous chorioretinopathy (CSC) is a common retina disease and has a relative high
recurrence rate, etiology, and pathogenesis of which remains largely ambiguous. The effects …

Central serous chorioretinopathy: An evidence-based treatment guideline

HMA Feenstra, EHC Van Dijk, CMG Cheung… - Progress in Retinal and …, 2024 - Elsevier
Central serous chorioretinopathy (CSC) is a relatively common disease that causes vision
loss due to macular subretinal fluid leakage and is often associated with reduced vision …

[HTML][HTML] Serous business: delineating the broad spectrum of diseases with subretinal fluid in the macula

EHC van Dijk, CJF Boon - Progress in retinal and eye research, 2021 - Elsevier
A wide range of ocular diseases can present with serous subretinal fluid in the macula and
therefore clinically mimic central serous chorioretinopathy (CSC). In this manuscript, we …

Risk factors for central serous chorioretinopathy: multivariate approach in a case-control study

I Chatziralli, SA Kabanarou, E Parikakis… - Current Eye …, 2017 - Taylor & Francis
Purpose: The purpose of this prospective study was to investigate the potential risk factors
associated independently with central serous retinopathy (CSR) in a Greek population …

A randomized double-blind placebo-control pilot study of eplerenone for the treatment of central serous chorioretinopathy (ecselsior)

E Rahimy, JD Pitcher III, J Hsu, MK Adam, A Shahlaee… - Retina, 2018 - journals.lww.com
Purpose: To evaluate the safety and effects of oral eplerenone in chronic central serous
chorioretinopathy. Methods: Prospective, randomized, double-blind, placebo-control study at …

Risk factors for recurrences of central serous chorioretinopathy

A Matet, A Daruich, M Zola, F Behar-Cohen - Retina, 2018 - journals.lww.com
Purpose: To describe recurrence patterns and investigate candidate risk factors for
recurrences of central serous chorioretinopathy. Methods: In 46 patients with acute central …

[HTML][HTML] Crossover to photodynamic therapy or micropulse laser after failure of primary treatment of chronic central serous chorioretinopathy: the REPLACE trial

TJ van Rijssen, EHC van Dijk, P Scholz… - American Journal of …, 2020 - Elsevier
Purpose To assess whether chronic central serous chorioretinopathy (cCSC) patients
without a complete resolution of subretinal fluid (SRF) after either half-dose photodynamic …

Non-resolving, recurrent and chronic central serous chorioretinopathy: available treatment options

F Sartini, M Figus, M Nardi, G Casini, C Posarelli - Eye, 2019 - nature.com
Central serous chorioretinopathy is one of the most frequent causes of vision reduction
among middle-aged men. This disease usually has a self-limiting course, but sometimes it …